GSK's cervical cancer vaccine gains approval in mainland China
- First approval of two-dose vaccine for cervical cancer in China- Vaccine significantly reduces incidence of cancer- Name change to GSK from GlaxoSmithKlinePharmaceutical company GSK (GSK) has received approval from China's Medical...
27 May 2022
